Family-based association study of SELENBP1 in schizophrenia

Schizophrenia Research

Volumn 113, Issue 2-3, 2009, Pages 268-272

  Kanazawa, Tetsufumi ^a,b   Glatt, Stephen J ^c   Faraone, Stephen V ^c   Hwu, Hai Gwo ^d,e   Yoneda, Hiroshi ^a   Tsuang, Ming T ^b,f,g  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Family based association study; Gene; Schizophrenia; SELENBP1; Selenium binding protein 1 gene

Indexed keywords

BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; FAMILY STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SELENIUM-BINDING PROTEINS; TAIWAN;

EID: 68049137313     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.06.011     Document Type: Article

References (18)

1. Brauer A.U., and Savaskan N.E. Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. Reviews of Neuroscience 15 (2004) 19-32
2. Brzustowicz L.M., Hodgkinson K.A., Chow E.W., Honer W.G., and Bassett A.S. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288 (2000) 678-872
3. Faraone S.V., Tsuang D., and Tsuang M.T. Genetics of mental disorders: a guide for students, clinicians, and researchers (1999), Guilford, New York, NY
4. Faraone S.V., Hwu H.G., Liu C.M., Chen W.J., Tsuang M.M., Liu S.K., Shieh M.H., Hwang T.J., Ou-Yang W.C., Chen C.Y., Chen C.C., Lin J.J., Chou F.H., Chueh C.M., Liu W.M., Hall M.H., Su J., Van Eerdewegh P., and Tsuang M.T. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. American Journal of Psychiatry 163 (2006) 1760-1766
5. Gauderman W.J., Witte J.S., and Thomas D.C. Family-based association studies. Journal of the National Cancer Institute Monographs (1999) 31-37
6. Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sasik R., Khanlou N., Han M., Liew C.C., and Tsuang M.T. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 15533-15538
7. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10 (2005) 40-68 [image 45]
8. Hwu H.G., Faraone S.V., Liu C.M., Chen W.J., Liu S.K., Shieh M.H., Hwang T.J., Tsuang M.M., OuYang W.C., Chen C.Y., Chen C.C., Lin J.J., Chou F.H., Chueh C.M., Liu W.M., Hall M.H., and Tsuang M.T. Taiwan schizophrenia linkage study: the field study. American Journal of Medical Genetics B Neuropsychiatric Genetics 134 (2005) 30-36
9. Kanazawa T., Chana G., Glatt S.J., Mizuno H., Masliah E., Yoneda H., Tsuang M.T., and Everall I.P. The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis. American Journal of Medical Genetics B Neuropsychiatric Genetics 147B 6 (2008) 689-689
10. Lange C., DeMeo D., Silverman E.K., Weiss S.T., and Laird N.M. PBAT: tools for family-based association studies. American Journal of Human Genetics 74 (2004) 367-369
11. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lönnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoëga T., and Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. American Journal of Human Genetics 73 (2003) 34-48
12. Miyaguchi K. Localization of selenium-binding protein at the tips of rapidly extending protrusions. Histochemistry and Cell Biology 121 (2004) 371-376
13. Oeth P., Beaulieu M., Park C., Kosman D., del Mistro G., van den Boom D., and Jurinke C. iPLEX™ assay: increased plexing efficiency and flexibility for MassARRAY system through single base primer extension with mass-modified terminators. City (2005) 1-12
14. Richardson D.R. More roles for selenoprotein P: local selenium storage and recycling protein in the brain. Biochemical Journal 386 (2005) e5-e7
15. Savaskan N.E., Brauer A.U., Kuhbacher M., Eyupoglu I.Y., Kyriakopoulos A., Ninnemann O., Behne D., and Nitsch R. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB Journal 17 (2003) 112-114
16. Schweizer U., Brauer A.U., Kohrle J., Nitsch R., and Savaskan N.E. Selenium and brain function: a poorly recognized liaison. Brain Research Brain Research Reviews 45 (2004) 164-178
17. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., Glatt S.J., and Liew C.C. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. American Journal of Medical Genetics B Neuropsychiatric Genetics 133 (2005) 1-5
18. Vaddadi K.S., Soosai E., and Vaddadi G. Low blood selenium concentrations in schizophrenic patients on clozapine. British Journal of Clinical Pharmacology 55 (2003) 307-309